Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | ESR1 | P03372 | 7/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 4/20 | 0.40 |
| ▸ | ARG1 | P05089 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29145926 | 0.90 | ALDH1A1 (0.45) | IDO1ALDH1A1PDE10AMAPTESR1 | |
| SCHEMBL11637154 | 0.85 | TUBB4A (0.47) | IDO1ALDH1A1MAPTHTTARG1 | |
| SCHEMBL28698738 | 0.85 | PDE10A (0.47) | ALDH1A1PDE10AMAPTESR1ESR2 | |
| Bromide SCHEMBL7741413 | 0.84 | TUBB4A (0.46) | IDO1ALDH1A1MAPTHTTARG1 | |
| SCHEMBL4466574 | 0.83 | ALDH1A1 (0.56) | ALDH1A1PDE10AMAPTESR1ESR2 | |
| SCHEMBL11256391 | 0.82 | ARG1 (0.55) | IDO1ALDH1A1MAPTTP53TDP1 | |
| SCHEMBL4574265 | 0.82 | ALDH1A1 (0.59) | ALDH1A1MAPTHTTTDP1CYP1A2 | |
| SCHEMBL11604188 | 0.80 | ALDH1A1 (0.53) | ALDH1A1MAPTESR1ESR2HTT | |
| SCHEMBL18480714 | 0.80 | ALDH1A1 (0.45) | ALDH1A1PDE10AMAPTESR1ESR2 | |
| SCHEMBL5809528 | 0.80 | ALDH1A1 (0.67) | ALDH1A1PDE10AMAPTESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212158-A1 | SMALL MOLECULE INHIBITORS OF GALECTIN-3 | BRISTOL MYERS SQUIBB CO (US) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212158-A1 | SMALL MOLECULE INHIBITORS OF GALECTIN-3 | LGALS3, LGALS1, LGALS3BP | IDO1 1111/4885ALDH1A1 2713/4885PDE10A 1694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.